N. Löschmann

发表

Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells

M. Michaelis, J. Cinatl, R. Zehner, 2014, PloS one.

Enzastaurin inhibits ABCB 1 mediated drug efflux independently of effects on protein kinase C signalling and the cellular

M. Michaelis, J. Cinatl, T. Ghafourian, 2019 .

Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status

M. Michaelis, J. Cinatl, T. Ghafourian, 2015, Oncotarget.

ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance

M. Michaelis, J. Cinatl, B. Blight, 2016, Oncotarget.

Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs.

F. Westermann, A. von Deimling, I. Fichtner, 2013, Translational oncology.

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen

Mark N. Wass, F. Westermann, M. Wass, 2015, Scientific Reports.

The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication

H. Doerr, M. Michaelis, J. Cinatl, 2011, Cellular and Molecular Life Sciences.

Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents

R. Breitling, A. von Deimling, A. Deimling, 2012, Cell Death and Disease.

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

R. Breitling, A. von Deimling, T. Stiewe, 2011, Cell Death and Disease.